NASDAQ: XRTX
Xortx Therapeutics Inc Stock Ownership - Who owns Xortx Therapeutics?

Insider buying vs selling

Have Xortx Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when XRTX insiders and whales buy or sell their stock.

XRTX Shareholders

What type of owners hold Xortx Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC7.61%265,000$251.22kInstitution
Ubs Group Ag0.50%17,428$16.52kInstitution
National Bank Of Canada0.05%1,613$1.53kInstitution
Royal Bank Of Canada0.04%1,493$1.42kInstitution
Osaic Holdings Inc0.03%1,153$1.09kInstitution
Clearstead Advisors LLC0.01%277$262.60Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

XRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XRTX8.24%0.00%
EYEN22.55%77.45%Net Buying
HEPA4.55%83.37%
PALI2.35%97.65%Net Selling
ENVB43.67%38.75%

Xortx Therapeutics Stock Ownership FAQ

Who owns Xortx Therapeutics?

Xortx Therapeutics (NASDAQ: XRTX) is owned by 8.24% institutional shareholders, 0.00% Xortx Therapeutics insiders, and 91.76% retail investors. Armistice Capital LLC is the largest individual Xortx Therapeutics shareholder, owning 265,000.00 shares representing 7.61% of the company. Armistice Capital LLC's Xortx Therapeutics shares are currently valued at $230.55k.

If you're new to stock investing, here's how to buy Xortx Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.